Visual Dysfunction of the Superior Colliculus in De Novo Parkinsonian Patients.


Journal

Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449

Informations de publication

Date de publication:
04 2020
Historique:
received: 17 07 2019
revised: 05 02 2020
accepted: 05 02 2020
pubmed: 8 2 2020
medline: 28 7 2020
entrez: 8 2 2020
Statut: ppublish

Résumé

The dual hit hypothesis about the pathogenesis of Parkinson disease (PD) suggests that the brainstem is a convergent area for the propagation of pathological α-synuclein from the periphery to the brain. Although brainstem structures are likely to be affected early in the course of the disease, detailed information regarding specific brainstem regions is lacking. The aim of our study was to investigate the function of the superior colliculus, a sensorimotor brainstem structure, in de novo PD patients compared to controls using brain functional magnetic imaging and visual stimulation paradigms. De novo PD patients and controls were recruited. PD subjects were imaged before and after starting PD medications. A recently developed functional magnetic resonance imaging protocol was used to stimulate and visualize the superior colliculus and 2 other visual structures: the lateral geniculate nucleus and the primary visual cortex. In the 22 PD patients, there was no modulation of the superior colliculus responses to the luminance contrasts compared to controls. This implies a hypersensitivity to low luminance contrast and abnormal rapid blood oxygenation level-dependent signal saturation to high luminance contrasts. The lateral geniculate nucleus was only modulated by 3 to 9% luminance contrasts compared to controls. No major differences were found in the primary visual cortex between both groups. Our findings suggest that pathological superior colliculus visual responses in de novo PD patients are present early in the course of the disease. Changes in imaging the superior colliculus could play an important role as a preclinical biomarker of the disease. ANN NEUROL 2020;87:533-546.

Identifiants

pubmed: 32030799
doi: 10.1002/ana.25696
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

533-546

Informations de copyright

© 2020 American Neurological Association.

Références

Spillantini MG, Schmidt ML, Lee VM, et al. Alpha-synuclein in Lewy bodies. Nature 1997;388:839-840.
Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord 2015;30:1591-1601.
Postuma RB, Berg D. Advances in markers of prodromal Parkinson's disease. Nat Rev Neurol 2016;12:622-634.
Postuma R. Dreaming in dementia-REM sleep behavior disorder and synucleinopathy. Mov Disord 2012;27:6-7.
Cooper CA, Chahine LM. Biomarkers in prodromal Parkinson's disease: a qualitative review. J Int Neuropsychol Soc 2016;22:956-967.
Hawkes CH, Del Tredici K, Braak H. Parkinson's disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 2007;33:599-614.
Thevathasan W, Moro E. What is the therapeutic mechanism of pedunculopontine nucleus stimulation in Parkinson's disease? Neurobiol Dis 2019;128:67-74.
Hopkins DA, Niessen LW. Substantia nigra projections to the reticular formation, superior colliculus and central gray in the rat, cat and monkey. Neurosci Lett 1976;2:253-259.
Comoli E, Coizet V, Boyes J, et al. A direct projection from superior colliculus to substantia nigra for detecting salient visual events. Nat Neurosci 2003;6:974-980.
Coizet V, Graham J, Moss J, et al. Short-latency visual input to the subthalamic nucleus is provided by the midbrain superior colliculus. J Neurosci 2009;29:5701-5709.
May PJ, McHaffie JG, Stanford TR, et al. Tectonigral projections in the primate: a pathway for pre-attentive sensory input to midbrain dopaminergic neurons. Eur J Neurosci 2009;29:575-587.
Rolland M, Carcenac C, Overton PG, et al. Enhanced visual responses in the superior colliculus and subthalamic nucleus in an animal model of Parkinson's disease. Neuroscience 2013;252:277-288.
Bellot E, Coizet V, Warnking J, et al. Effect of aging on low luminance contrast processing in humans. Neuroimage 2016;139:415-426.
Hoehn M, Yahr M. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
Goetz CG, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 2007;22:41-47.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state for the clinician. J Psychiatr Res 1975;12:189-198.
Schneider KA, Kastner S. Effects of sustained spatial attention in the human lateral geniculate nucleus and superior colliculus. J Neurosci 2009;29:1784-1795.
Rorden C, Brett M. Stereotaxic display of brain lesions. Behav Neurol 2000;12:191-200.
Hupé JM, Bordier C, Dojat M. A BOLD signature of eyeblinks in the visual cortex. Neuroimage 2012;61:149-161.
Erskine D, Thomas AJ, Taylor JP, et al. Neuronal loss and alpha-synuclein pathology in the superior colliculus and its relationship to visual hallucinations in dementia with Lewy Bodies. Am J Geriatr Psychiatry 2017;25:595-604.
May PJ. The mammalian superior colliculus: laminar structure and connections. Prog Brain Res 2006;151:321-378.
Edwards SB, Ginsburgh CL, Henkel CK, Stein BE. Sources of subcortical projections to the superior colliculus in the cat. J Comp Neurol 1979;184:309-329.
Gauriau C, Bernard JF. Pain pathways and parabrachial circuits in the rat. Exp Physiol 2002;87:251-258.
Berg EA, Johnson RJ, Leeman SE, et al. Isolation and characterization of substance P-containing dense core vesicles from rabbit optic nerve and termini. J Neurosci Res 2000;62:830-839.
Beach TG, Carew J, Serrano G, et al. Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects. Neurosci Lett 2014;571:34-38.
Wurtz RH, Albano JE. Visual-motor function of the primate superior colliculus. Annu Rev Neurosci 1980;3:189-226.
Sparks DL. Translation of sensory signals into commands for control of saccadic eye movements: role of primate superior colliculus. Physiol Rev 1986;66:118-171.
Basso MA, May PJ. Circuits for action and cognition: a view from the superior colliculus. Annu Rev Vis Sci 2017;3:197-226.
Crapse TB, Lau H, Basso MA. A role for the superior colliculus in decision criteria. Neuron 2018;97:181-194.
Chamber JM, Prescott TJ. Response times for visually guided saccades in persons with Parkinson's disease: a meta-analytic review. Neuropsychologia 2010; 48:887-899.
Terao Y, Fukuda H, Ugawa Y, Hikosaka O. New perspectives on the pathophysiology of Parkinson's disease as assessed by saccade performance: a clinical review. Clin Neurophysiol 2013;124:354-363.
Chang F, Armstrong IT, Paria G, et al. Deficits in saccadic eye-movement control in Parkinson's disease. Neuropsychology 2005;43:784-796.
van Stockum S, Macaskill MR, Myall D, Anderson TJ. A perceptual discrimination task abnormally facilitates reflexive saccades in Parkinson's disease. Eur J Neurosci 2011;33:2091-2100.
Marino RA, Levy R, Boehnke S, et al. Linking visual response properties in the superior colliculus to saccade behavior. Eur J Neurosci 2012;35:1738-1752.
Rahimi J, Milenkovic I, Kovacs GG. Patterns of tau and α-synuclein pathology in the visual system. J Parkinsons Dis 2015;5:333-340.
Usrey WM, Alitto HJ. Visual functions of the thalamus. Annu Rev Vis Sci 2015;1:351-371.
Thirion B, Pinel P, Mériaux S, et al. Analysis of a large fMRI cohort: statistical and methodological issues for group analyses. Neuroimage 2007;35:105-120.

Auteurs

Elena Moro (E)

Division of Neurology, Grenoble University Hospital Center, Grenoble, France.

Emmanuelle Bellot (E)

Grenoble Alpes University, Grenoble Institute of Neurosciences, Grenoble, France.

Sara Meoni (S)

Division of Neurology, Grenoble University Hospital Center, Grenoble, France.

Pierre Pelissier (P)

Division of Neurology, Grenoble University Hospital Center, Grenoble, France.

Ruxandra Hera (R)

Retina Alpes, Montbonnot, France.

Michel Dojat (M)

Grenoble Alpes University, Grenoble Institute of Neurosciences, Grenoble, France.

Veronique Coizet (V)

Grenoble Alpes University, Grenoble Institute of Neurosciences, Grenoble, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH